Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska

Emerging Infectious Diseases

Volumn 14, Issue 11, 2008, Pages 1693-1699

  David, Michael Z ^a   Rudolph, Karen M ^b   Hennessy, Thomas W ^b   Boyle Vavra, Susan ^a   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; MOLECULAR EPIDEMIOLOGY; RURAL AREA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ALASKA; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHROMOSOMES, BACTERIAL; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; EXOTOXINS; GENES, BACTERIAL; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RURAL POPULATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 55549120232     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1411.080381     Document Type: Article

References (35)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-32. DOI: 10.1056/NEJM199808203390806
2. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis. 2005;40:1785-91. DOI: 10.1086/430312
3. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus in three communities. N Engl J Med. 2005;352:1436-44. DOI: 10.1056/NEJMoa043252
4. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-84. DOI: 10.1001/jama.290.22.2976
5. David MZ, Glikman D, Crawford SE, Peng J, King K, Hostetler MA, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008;197:1235-43. DOI: 10.1086/533502
6. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315:1130-3. DOI: 10.1126/science.1137165
7. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006;194:1761-70. DOI: 10.1086/509506
8. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-74. DOI: 10.1056/NEJMoa055356
9. Pan ES, Diep BA, Charlebois ED, Auerswald C, Carleton HA, Sensabuagh GF, et al. Population dynamics of methicillin-resistant Staphylococcus aureus-and their relation to community-associated disease activity. J Infect Dis. 2005;192:811-8. DOI: 10.1086/432072
10. Furtado N, Mangat PD, Frank AL, Janda W, Boyle S, Daum RS. Two clindamycin susceptible (community associated) MRSA epidemics in Chicago. In: Program and abstracts of the Infectious Diseases Society of America (IDSA); Toronto, Ontario, Canada; November 15, 2006. Abstract 378.
11. Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin- resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007;13:594-600.
12. Landen MG, McCumber BJ, Asam ED, Egeland GM. Outbreak of boils in an Alaskan village: a case-control study. West J Med. 2000;172:235-9. DOI: 10.1136/ewjm.172.4.235
13. Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 2003;24:397-402. DOI: 10.1086/502221
14. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and cytotoxin Panton-Valentin leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis. 2004;189:1565-73. DOI: 10.1086/383247
15. Pan ES, Diep BA, Carleton HA, Charlebois ED, Sensabaugh GF, Haller BL, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis. 2003;37:1384-8. DOI: 10.1086/379019
16. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008-15.
17. BURST - based upon related sequence types [cited 2008 Mar 1]. Available from http://linux.mlst.net/burst.htm
18. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol. 2005;43:4719-30. DOI: 10.1128/JCM.43.9.4719-4730.2005
19. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine-leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32. DOI: 10.1086/313461
20. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA. 1999;282:1123-5. DOI: 10.1001/jama.282.12.1123
21. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-27. DOI: 10.1016/S0140-6736(02)08713-5
22. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-20. DOI: 10.1128/JCM.41.11. 5113-5120.2003
23. Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, Heck ME, Pluister GN, Eijkelkamp BA, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006;44:2994-6. DOI: 10.1128/JCM.00846-06
24. Fossum AE, Bukholm G. Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmec IV in the south-eastern part of Norway during a 12-year period. Clin Microbiol Infect. 2006;12:627-33. DOI: 10.1111/j.1469-0691.2006.01467.x
25. Brady JM, Stemper ME, Weigel A, Chyou PH, Reed KD, Shukla SK. Sporadic "transitional" community-associated methicillin-resistant Staphylococcus aureus strains from health care facilities in the United States. J Clin Microbiol. 2007;45:2654-61. DOI: 10.1128/JCM.02579-06
26. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet. 2005;365:1256-8. DOI: 10.1016/S0140-6736(05)74814-5
27. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006;193:1495-503. DOI: 10.1086/503777
28. Ma XX, Ito T, Chongtrakool P, Hiramatsu K. Predominance of clones carrying Panton-Valentine leukocidin genes among methicillin-resistant Staphylococcus aureus strains isolated in Japanese hospitals from 1979 to 1985. J Clin Microbiol. 2006;44:4515-27. DOI: 10.1128/JCM.00985-06
29. Faria NA, Oliviera DC, Westh H, Monnet DL, Larsen AR, Skov R, et al. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol. 2005;43:1836-42. DOI: 10.1128/JCM.43.4.1836-1842. 2005
30. Taneike I, Otsuka T, Dohmae S, Saito K, Ozaki K, Takano M, et al. Molecular nature of methicillin-resistant Staphylococcus aureus derived from explosive nosocomial outbreaks of the 1980s in Japan. FEBS Lett. 2006;580:2323-34. DOI: 10.1016/j.febslet.2006.03.049
31. Durand G, Bes M, Meugnier H, Enright MC, Forey F, Liassine N, et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol. 2006;44:847-53. DOI: 10.1128/JCM.44.3.847-853.2006
32. O'Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA, et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol. 2004;42:3185-90. DOI: 10.1128/JCM.42.7.3185-3190.2004
33. O'Hara FP, Guex N, Word JM, Miller LA, Becker JA, Walsh SL, et al. A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis. 2008;197:187-94. DOI: 10.1086/524684
34. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-8. DOI: 10.1128/AAC.01244-06
35. Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008;148:249-57.